Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Biosciences"
DOI: 10.1007/s12038-018-9797-7
Abstract: Loratadine is a selective inverse agonist of peripheral histamine H1-receptors. Microbial biotransformation gained a lot of attention for its ability to convert molecules to valuable medicinally active substances. The main objective of the present research…
read more here.
Keywords:
evaluation fungal;
screening evaluation;
resources loratadine;
spectroscopy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00292
Abstract: Gastrointestinal anatomical/physiological changes after bariatric surgery influence variables affecting the fate of drugs after ingestion, and medication management of these patients requires a thorough and complex mechanistic analysis. The aim of this research was to…
read more here.
Keywords:
desloratadine;
dissolution;
surgery;
solubility ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2021.1973039
Abstract: Abstract Context Desloratadine, an H1 receptor antagonist, is suggested as an effective first-line drug for chronic urticarial (CU). However, the efficacy of desloratadine alone is limited, and the recurrence rate of CU is relatively high.…
read more here.
Keywords:
compound glycyrrhizin;
desloratadine;
treatment;
combination ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Pharmaceutical Sciences"
DOI: 10.34172/ps.2020.59
Abstract: Background: Active pharmaceutical ingredients face a challenge in manufacturing due to adverse physicomechanical properties. Desloratadine (DES) form I exhibits poor mechanical behavior through the formation of capping during the tableting process. Salt formation from DES…
read more here.
Keywords:
polymorphic transformation;
desloratadine;
des des;
transformation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Indian Journal of Dermatology"
DOI: 10.4103/ijd.ijd_546_17
Abstract: Background: The etiopathogeny of chronic spontaneous urticaria (CSU) is not well defined. Allelism in glutathione S-transferase GSTM1 and GSTT1 has been suggested as a risk factor. Desloratadine is the first-line treatment for this disease. Objective:…
read more here.
Keywords:
desloratadine;
efficacy;
treatment;
gstm1 ... See more keywords